Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2022-04-28 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
2021年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021年度股东大会决议公告" which translates to "2021 Annual General Meeting Resolution Announcement." It details the date and method of the meeting, attendance, voting results on various proposals including the annual report, financial statements, profit distribution, election of board members, and amendments to company rules. It also includes a legal opinion confirming the validity of the meeting and resolutions. The document is a formal announcement of the voting results and resolutions passed at the Annual General Meeting (AGM). It does not contain the full annual report or financial statements themselves but reports on the outcomes of the AGM. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (6724 characters) and detailed voting results support this classification with high confidence.
2022-04-28 Chinese
安徽承义律师事务所关于华兰生物工程股份有限公司首2018年限制性股票激励计划预留授予的限制性股票第二个解除限售期解锁条件成就的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the conditions and approval of the second unlocking period of restricted stock under a 2018 restricted stock incentive plan of a company. It details the legal compliance, approval procedures, and conditions met for the stock unlocking. It is not a financial report, earnings release, or management discussion, but a legal opinion related to stock incentive plan implementation. This type of document fits best under Regulatory Filings (RNS) as it is a legal compliance and opinion document rather than a financial or management report.
2022-04-28 Chinese
安徽承义律师事务所关于华兰生物工程股份有限公司召开2021年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening and proceedings of the 2021 Annual General Meeting (AGM) of the company 华兰生物工程股份有限公司. It details the qualifications of the meeting convener, attendees, proposals considered, voting procedures, and results of the AGM. The document does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM process and resolutions passed. This type of document is typically classified as AGM Information (AGM-R) because it relates to materials shared or opinions issued in connection with the AGM, rather than the annual report itself or voting results announcement alone. The document length (6510 characters) and content support this classification.
2022-04-28 Chinese
独立董事关于第八届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters related to the first meeting of the eighth board of directors, including the appointment of senior management and the unlocking of restricted stock under a stock incentive plan. It references compliance with company law, stock incentive regulations, and internal company rules. The content focuses on governance and management decisions rather than financial results, audit, or regulatory filings. It is not a full report, earnings release, or announcement of voting results. The document fits best under Board/Management Information (MANG) as it concerns board meeting decisions and management appointments.
2022-04-28 Chinese
2022年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "华兰生物工程股份有限公司 2022 年第一季度报告全文" which translates to "Hualan Biological Engineering Co., Ltd. 2022 First Quarter Report Full Text." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the first quarter of 2022. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It is not an announcement or a brief summary but a full report with substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2022-04-28 Chinese
董事会战略委员会工作细则
Governance Information Classification · 95% confidence The document is a detailed set of rules and procedures for the Board's Strategic Committee, including its composition, responsibilities, meeting protocols, and decision-making processes. It is a governance-related document outlining internal board committee governance and operational guidelines. There is no financial data, no report publication, no voting results, no management changes, no earnings or capital updates, and no legal proceedings. The content fits the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2022-04-28 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.